fda warning bpc-157 compounded peptide safety concerns panel backs BPC-157, KPV peptides in win for RFK Jr FDA's Overreach on Compounded Peptides

(Study: Ng et al., 2000) Clinical Applications: AOD 9604 may be considered as an option for individuals struggling with obesity when other treatments prove ineffective or unsuitable

Separate reporting from office visit : If done during an E/M visit (e.g., 99213), Modifier 25 may be required on the E/M code to indicate the injection is a separately identifiable service

How MIC Injections Compare to GLP-1 Medications GLP-1 Medications GLP-1 agonists like Ozempic , Wegovy , and Mounjaro have become popular for weight management and for some patients, they can be helpful

Creatine deficiency in the brain: A new, treatable inborn error of metabolism